• A
• B
• C
• D
• E
• F
• G
• H
• I
• K
• L
• M
• N
• O
• P
• R
• S
• T
• U
• V
• Z

Nilotinib (Tasigna®) newly diagnosed CML

Nintedanib (Ofev®)

Nintedanib (Ofev®) HTA ID: 20034

Nintedanib (Vargatef®)

Niraparib (Zejula®); 1L maintenance OVCA. HTA ID: 21004

Niraparib (Zejula®); Recurrent OVCA maintenance treatment

Nirmatrelvir/Ritonavir (Paxlovid®). HTA ID: 22014

Nivolumab (Opdivo®) as monotherapy for the adjuvant treatment of adults with melanoma

Nivolumab (Opdivo®) as monotherapy for unresectable advanced, recurrent, or metastatic oesophageal squamous cell carcinoma (2L). HTA ID: 20057

Nivolumab (Opdivo®) for adjuvant treatment of oesophageal or gastro-oesophageal junction cancer. HTA ID: 21043